ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript May 9, 2024
ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.07532, expectations were $0.05. ADMA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good afternoon, and welcome to the ADMA Biologics First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 09, 2024. At this time, all participants are...
